Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans

Genes and Immunity

Volumn 4, Issue 4, 2003, Pages 245-250

  Duggal, P ^a   An, P ^b   Beaty, T H ^a   Strathdee, S A ^a   Farzadegan, H ^a   Markham, R B ^a   Johnson, L ^a   O'Brien, S J ^c   Vlahov, D ^a   Winkler, C A ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; Chemokine; Chemokine receptor; HIV; Pneumocystic carinii pneumonia

Indexed keywords

ADENINE; ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR6; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; CXCR6 PROTEIN, HUMAN; CYTOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CAUSE OF DEATH; CODON; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; UNITED STATES; VIRUS INFECTION; COMPARATIVE STUDY; ETHNOLOGY; GENETICS; MORTALITY; SURVIVAL;

HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS CARINII; SIMIAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AFRICAN AMERICANS; ALLELES; BALTIMORE; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; PNEUMONIA, PNEUMOCYSTIS; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VIRUS; SURVIVAL ANALYSIS;

EID: 9444265985     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363950     Document Type: Article

References (22)

1. Michael NL. Host genetic influences on HIV-1 pathogenesis. Curr Opin Immunol 1999; 11: 466-474.
2. O'Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 2000; 177: 99-111.
3. O'Brien SJ, Nelson GW, Winkler CA, Smith MW. Polygenic and multifactorial disease gene association in man: lessons from AIDS. Annu Rev Genet 2000; 34: 563-591.
4. Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862.
5. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-965.
6. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393.
7. Deng HK, Unutmaz D, Kewalramani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997; 388: 296-300.
8. Liao F, Alkhatib G, Peden KW et al. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997; 185: 2015-2023.
9. Loetscher M, Amara A, Oberlin E et al. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr Biol 1997; 7: 652-660.
10. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298-304.
11. Wilbanks A, Zondlo SC, Murphy K et al. Expression cloning of the strl33/bonzo/tymstr ligand reveals elements of cc, cxc, and cx3c chemokines. J Immunol 2001; 166: 5145-5154.
12. Kim CH, Kunkel EJ, Boisvert J et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 2001; 107: 595-601.
13. Szklo M, Nieto J. Epidemiology: Beyond the Basics, 1st edn. Aspen Publishers: Gaithersburg, 2000.
14. Shellito JE, Tate C, Ruan S, Kolls J. Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii. J Infect Dis 2000; 181: 2011-2017.
15. Motsinger A, Haas DW, Stanic AK et al. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002; 195: 869-879.
16. Sharron M, Pohlmann S, Price K et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood 2000; 96: 41-49.
17. Vlahov D, Anthony JC, Munoz A et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109: 75-100.
18. Daugherty BL, Springer MS. The beta-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) cluster within 285kb on human chromosome 3p21. Genomics 1997; 41: 294-295.
19. 1987 revision of the Center for Disease Control/World Health Organization definition of cases of acquired immunodeficiency syndrome (AIDS). Bol Oficina Sanit Panam 1988; 104: 277-286.
20. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 1-19.
21. Vlahov D, Graham N, Hoover D et al. Prognostic indicators for AIDS and infectious disease death in HIV- infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279: 35-40.
22. DHHS/Henry J Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected adults and adolescents. MMWR Recomm Rep 2002 May 17; 51 (RR-7): 1-55.